Comparison

Copanlisib European Partner

Item no. TMO-T6322-100mg
Manufacturer TargetMol
CASRN 1032568-63-0
Amount 100mg
Category
Type Molecules
Specific against other
Purity 0,98
Smiles COc1c(OCCCN2CCOCC2)ccc2C3=NCCN3C(NC(=O)c3cnc(N)nc3)=Nc12
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias BAY 80-6946
Available
Short Description
Copanlisib is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the PI3K signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.
Shipping
cool pack
Storage
-20°
Target names or alias
BAY 80-6946
Molecular Weight
480, 52
Pathway
Apoptosis|||PI3K/Akt/mTOR signaling
Target
PI3K|||Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close